/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Citius Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.18 -0.0913(-9.13%) CTXR at 04 Dec 2025 04:29 PM Biotechnology
Lowest Today 1.145
Highest Today 1.275
Today’s Open 1.275
Prev. Close 1.26
52 Week High 5.95
52 Week Low 0.65
Day’s Range: Low 1.145 High 1.275
52-Week Range: Low 0.65 High 5.95
1 day return -
1 Week return -20.27
1 month return -16.17
3 month return -
6 month return +34.43
1 year return -68.68
3 year return -3.38
5 year return -
10 year return -

Institutional Holdings

UBS Group AG 1.13

CAMBRIDGE Invest RESEARCH ADVISORS, INC. 1.08

Heights Capital Management Inc 0.94

Vanguard Group Inc 0.47

Geode Capital Management, LLC 0.45

Vanguard Institutional Extnd Mkt Idx Tr 0.41

BlackRock Inc 0.41

Fidelity Extended Market Index 0.30

Goss Wealth Management LLC 0.15

State Street Corp 0.14

XTX Topco Ltd 0.12

Arkadios Wealth Advisors 0.12

Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 0.10

Northern Trust Corp 0.08

Susquehanna International Group, LLP 0.08

Fidelity Series Total Market Index 0.08

Two Sigma Investments LLC 0.08

Fidelity Total Market Index 0.07

Extended Equity Market Fund K 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

IFP Advisors, LLC 0.04

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

Spartan Total Market Index Pool G 0.03

NT Ext Equity Mkt Idx Fd - NL 0.03

Chelsea Management Company 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

SBI Securities Co Ltd 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

State St US Extended Mkt Indx NL Cl C 0.01

Vanguard U.S. Eq Idx £ Acc 0.01

Advisor Group Holdings, Inc. 0.01

NT Ext Eq Mkt Indx Fd DC Lend T3 0.01

Extended Equity Market Fund M 0.01

SSgA U.S. Total Market Index Strategy 0.00

Group One Trading, LP 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Luminist Capital LLC 0.00

Spartan Extended Market Index Pool F 0.00

Northern Trust Wilshire 5000 0.00

Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 23.27 M

PB Ratio 0.4089

PE Ratio 0.0

Enterprise Value 22.39 M

Total Assets 116.65 M

Volume 526245

Company Financials

Annual Revenue FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY24:-39425839 -39.4M, FY23:-32542912 -32.5M, FY22:-33640646 -33.6M, FY21:-23125190 -23.1M, FY20:-17673965 -17.7M

Quarterly Revenue Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:155926 0.2M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q2/2025:-41367 -0.0M, Q1/2025:-56010 -0.1M, Q4/2024:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-52848 -0.1M

Quarterly Net worth Q2/2025:-8789872 -8.8M, Q1/2025:-10916505 -10.9M, Q4/2024:-9768246 -9.8M, Q3/2024:-10790164 -10.8M, Q2/2024:-10573336 -10.6M

Fund house & investment objective

Company Information Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Organisation Biotechnology

Employees 23

Industry Biotechnology

CEO Mr. Leonard L. Mazur

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow